Kairos Pharma, Ltd.'s total assets for Q1 2025 were $7.94M, an increase of 37.60% from the previous quarter. KAPA total liabilities were $805.00K for the fiscal quarter, a -18.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.